Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
Public ClinicalTrials.gov record NCT04041310. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase I/II, Multicenter, Open-Label Study of Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
Study identification
- NCT ID
- NCT04041310
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Nouscom SRL
- Industry
- Enrollment
- 115 participants
Conditions and interventions
Conditions
Interventions
- GAd-209-FSP high dose Biological
- GAd-209-FSP low dose Biological
- GAd20-209-FSP, RP2D Biological
- KEYTRUDA® Drug
- MVA-209-FSP high dose Biological
- MVA-209-FSP low dose Biological
- MVA-209-FSP, RP2D Biological
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 20, 2019
- Primary completion
- Oct 29, 2026
- Completion
- Oct 29, 2026
- Last update posted
- Feb 12, 2026
2019 – 2026
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Comprehensive Cancer Center | Duarte | California | 91010 | — |
| City of Hope Comprehensive Cancer Center | Irvine | California | 92618 | — |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90089 | — |
| USC Norris Comprehensive Cancer Center | Newport Beach | California | 92663 | — |
| Mt. Sinai | Miami Beach | Florida | 33140 | — |
| Boca Raton Clinical Research | Plantation | Florida | 33322 | — |
| Goshen Center for Cancer Care | Goshen | Indiana | 46526 | — |
| Johns Hopkins University | Baltimore | Maryland | 21287 | — |
| Washington University School of Medicine, Division of Oncology | St Louis | Missouri | 63110 | — |
| Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14203 | — |
| NYU Langone Medical Center | New York | New York | 10016 | — |
| Weill Cornell Medicine / New York-Presbyterian Hospital | New York | New York | 10021 | — |
| MD Anderson Cancer Center (MDACC) | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04041310, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 12, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04041310 live on ClinicalTrials.gov.